HopeStage
Back to all studies
TerminatedNCT03397446

Lisdexamfetamine for Adults With Eating disorders

Medication studyAges 18–55Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
HalifaxSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 21, 2018
Recruitment status
Terminated
Enrollment listed in the registry
23
Sponsor
Aaron Keshen
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT03397446
Official title
Show the full official title

A Feasibility Study to Evaluate Lisdexamfetamine Dimesylate (Vyvanse) in Adults With Bulimia Nervosa

Recruitment & locations

Terminated

Halifax

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Aaron Keshen.

Does this study involve medication?

Yes. The study involves medication, including Lisdexamfetamine dimesylate.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies